Genetic Profile in Genes Associated with Sports Injuries in Elite Endurance Athletes

Abstract

Injuries are a complex trait that can stem from the interaction of several genes. The aim of this research was to examine the relationship between muscle performance-related genes and overuse injury risk in elite endurance athletes, and to examine the feasibility of determining a total genotype score that significantly correlates with injury. A cohort of 100 elite endurance athletes (50 male and 50 female) was selected. AMPD1 (rs17602729), ACE (rs4646994), ACTN3 (rs1815739), CKM (rs8111989) and MLCK ([rs2849757] and [rs2700352]) polymorphisms were genotyped by using real-time polymerase chain reaction (real time-PCR). Injury characteristics during the athletic season were classified following the Consensus Statement for injuries evaluation. The mean total genotype score (TGS) in non-injured athletes (68.263±13.197 arbitrary units [a.u.]) was different from that of injured athletes (50.037±17.293 a.u., p<0.001). The distribution of allelic frequencies in the AMPD1 polymorphism was also different between non-injured and injured athletes (p<0.001). There was a TGS cut-off point (59.085 a.u.) to discriminate non-injured from injured athletes with an odds ratio of 7.400 (95% CI 2.548–21.495, p<0.001). TGS analysis appears to correlate with elite endurance athletes at higher risk for injury. Further study may help to develop this as one potential tool to help predict injury risk in this population.

Key words

athletic performance - muscle performance - genes - injuries - single-nucleotide polymorphisms

Publication History

Received: 24 March 2022

Accepted: 03 August 2022

Accepted Manuscript online:
03 August 2022

Article published online:
29 September 2022

• References

• 1 Zanini G, De Gaetano A, Selleri V. et al. Mitochondrial DNA and exercise: implications for health and injuries in sports. Cells 2021; 10: 2575 DOI: 10.3390/cells10102575.
• 2 Al-Khelaifi F, Diboun I, Donati F. et al. A pilot study comparing the metabolic profiles of elite-level athletes from different sporting disciplines. Sports Med Open 2018; 4: 2 DOI: 10.1186/s40798-017-0114-z.
• 3 Lee EC, Fragala MS, Kavouras SA. et al. Biomarkers in sports and exercise: tracking health, performance, and recovery in athletes. J Strength Cond Res 2017; 31: 2920-2937 DOI: 10.1519/jsc.0000000000002122.
• 4 Petibois C, Cazorla G, Poortmans JR. et al. Biochemical aspects of overtraining in endurance sports: a review. Sports Med 2002; 32: 867-878 DOI: 10.2165/00007256-200232130-00005.
• 5 Baumert P, Lake MJ, Stewart CE. et al. Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing. Eur J Appl Physiol 2016; 116: 1595-1625 DOI: 10.1007/s00421-016-3411-1.
• 6 Gibson WT. Core concepts in human genetics: understanding the complex phenotype of sport performance and susceptibility to sport injury. Med Sport Sci 2016; 61: 1-14 DOI: 10.1159/000445237.
• 7 Lippi G, Longo UG, Maffulli N. Genetics and sports. Br Med Bull 2010; 93: 27-47 DOI: 10.1093/bmb/ldp007.
• 8 Feng AF, Liu ZH, Zhou SL. et al. Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a meta-analysis. BMC Cardiovasc Disord 2017; 17: 174 DOI: 10.1186/s12872-017-0608-0.
• 9 Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J Inherit Metab Dis 1997; 20: 186-192 DOI: 10.1023/a:1005352605421.
• 10 McCabe K, Collins C. Can genetics predict sports injury? The association of the genes GDF5, AMPD1, COL5A1 and IGF2 on soccer player injury occurrence. Sports (Basel) 2018; 6: 21 DOI: 10.3390/sports6010021.
• 11 Eynon N, Hanson ED, Lucia A. et al. Genes for elite power and sprint performance: ACTN3 leads the way. Sports Med 2013; 43: 803-817 DOI: 10.1007/s40279-013-0059-4.
• 12 Massidda M, Miyamoto-Mikami E, Kumagai H. et al. Association between the ACE I/D polymorphism and muscle injuries in Italian and Japanese elite football players. J Sports Sci 2020; 38: 2423-2429 DOI: 10.1080/02640414.2020.1787683.
• 13 Massidda M, Voisin S, Culigioni C. et al. ACTN3 R577X polymorphism is associated with the incidence and severity of injuries in professional football players. Clin J Sport Med 2019; 29: 57-61 DOI: 10.1097/jsm.0000000000000487.
• 14 Del Coso J, Hiam D, Houweling P. et al. More than a ‘speed gene’: ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries. Eur J Appl Physiol 2019; 119: 49-60 DOI: 10.1007/s00421-018-4010-0.
• 15 Garton FC, North KN. The effect of heterozygosity for the ACTN3 null allele on human muscle performance. Med Sci Sports Exerc 2016; 48: 509-520 DOI: 10.1249/mss.0000000000000784.
• 16 Eider J, Ahmetov II, Fedotovskaya ON. et al. CKM gene polymorphism in Russian and Polish rowers. Genetika 2015; 51: 389-392 DOI: 10.7868/s0016675815030029.
• 17 Zhou DQ, Hu Y, Liu G. et al. Muscle-specific creatine kinase gene polymorphism and running economy responses to an 18-week 5000-m training programme. Br J Sports Med 2006; 40: 988-991 DOI: 10.1136/bjsm.2006.029744.
• 18 Fedotovskaia ON, Popov DV, Vinogradova OL. et al. [Association of the muscle-specific creatine kinase (CKMM) gene polymorphism with physical performance of athletes]. Fiziol Cheloveka 2012; 38: 105-109
• 19 Del Coso J, Valero M, Lara B. et al. Myosin light chain kinase (MLCK) gene influences exercise induced muscle damage during a competitive marathon. PLoS One 2016; 11: e0160053 DOI: 10.1371/journal.pone.0160053.
• 20 Clarkson PM, Hoffman EP, Zambraski E. et al. ACTN3 and MLCK genotype associations with exertional muscle damage. J Appl Physiol (1985) 2005; 99: 564-569 DOI: 10.1152/japplphysiol.00130.2005.
• 21 Timpka T, Alonso JM, Jacobsson J. et al. Injury and illness definitions and data collection procedures for use in epidemiological studies in athletics (track and field): consensus statement. Br J Sports Med 2014; 48: 483-490 DOI: 10.1136/bjsports-2013-093241.
• 22 Williams AG, Folland JP. Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol 2008; 586: 113-121 DOI: 10.1113/jphysiol.2007.141887.
• 23 Ruiz JR, Gomez-Gallego F, Santiago C. et al. Is there an optimum endurance polygenic profile?. J Physiol 2009; 587: 1527-1534 DOI: 10.1113/jphysiol.2008.166645.
• 24 Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577
• 25 Muniesa CA, Gonzalez-Freire M, Santiago C. et al. World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes. Br J Sports Med 2010; 44: 898-901 DOI: 10.1136/bjsm.2008.051680.
• 26 Varillas Delgado D, Telleria Orriols JJ, Martin Saborido C. Liver-metabolizing genes and their relationship to the performance of elite spanish male endurance athletes; a prospective transversal study. Sports Med Open 2019; 5: 50 DOI: 10.1186/s40798-019-0227-7.
• 27 Varillas Delgado D, Tellería Orriols JJ, Monge Martín D. et al. Genotype scores in energy and iron-metabolising genes are higher in elite endurance athletes than in nonathlete controls. Appl Physiol Nutr Metab 2020; 45: 1225-1231 DOI: 10.1139/apnm-2020-0174.
• 28 Vlahovich N, Hughes DC, Griffiths LR. et al. Genetic testing for exercise prescription and injury prevention: AIS-Athlome consortium-FIMS joint statement. BMC Genomics 2017; 18: 818 DOI: 10.1186/s12864-017-4185-5.
• 29 Balberova OV, Bykov EV, Medvedev GV. et al. Candidate genes of regulation of skeletal muscle energy metabolism in athletes. Genes (Basel) 2021; 12: 1682 DOI: 10.3390/genes12111682.
• 30 Varillas-Delgado D, Del Coso J, Gutiérrez-Hellín J. et al. Genetics and sports performance: the present and future in the identification of talent for sports based on DNA testing. Eur J Appl Physiol 2022; 122: 1811-1830 DOI: 10.1007/s00421-022-04945-z.
• 31 Rico-Sanz J, Rankinen T, Joanisse DR. et al. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study. Physiol Genomics 2003; 14: 161-166 DOI: 10.1152/physiolgenomics.00165.2002.
• 32 Rubio JC, Martin MA, Rabadan M. et al. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance?. J Appl Physiol (1985) 2005; 98: 2108-2112 DOI: 10.1152/japplphysiol.01371.2004.
• 33 Gineviciene V, Jakaitiene A, Pranculis A. et al. AMPD1 rs17602729 is associated with physical performance of sprint and power in elite Lithuanian athletes. BMC Genet 2014; 15: 58 DOI: 10.1186/1471-2156-15-58.
• 34 Lucia A, Martin MA, Esteve-Lanao J. et al. C34T mutation of the AMPD1 gene in an elite white runner. BMJ Case Rep 2009; 2009 bcr07.2008.0535 DOI: 10.1136/bcr.07.2008.0535.
• 35 Saragiotto BT, Yamato TP, Hespanhol Junior LC. et al. What are the main risk factors for running-related injuries?. Sports Med 2014; 44: 1153-1163 DOI: 10.1007/s40279-014-0194-6.
• 36 Moran CN, Vassilopoulos C, Tsiokanos A. et al. The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents. Eur J Hum Genet 2006; 14: 332-339 DOI: 10.1038/sj.ejhg.5201550.
• 37 Scott RA, Moran C, Wilson RH. et al. No association between angiotensin converting enzyme (ACE) gene variation and endurance athlete status in Kenyans. Comp Biochem Physiol A Mol Integr Physiol 2005; 141: 169-175 DOI: 10.1016/j.cbpb.2005.05.001.
• 38 Myerson S, Hemingway H, Budget R. et al. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol (1985) 1999; 87: 1313-1316 DOI: 10.1152/jappl.1999.87.4.1313.
• 39 Nazarov IB, Woods DR, Montgomery HE. et al. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet 2001; 9: 797-801 DOI: 10.1038/sj.ejhg.5200711.
• 40 Amir O, Amir R, Yamin C. et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol 2007; 92: 881-886 DOI: 10.1113/expphysiol.2007.038711.
• 41 Costa AM, Silva AJ, Garrido ND. et al. Association between ACE D allele and elite short distance swimming. Eur J Appl Physiol 2009; 106: 785-790 DOI: 10.1007/s00421-009-1080-z.
• 42 Yang N, MacArthur DG, Gulbin JP. et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003; 73: 627-631 DOI: 10.1086/377590.
• 43 Clos E, Pruna R, Lundblad M. et al. ACTN3 single nucleotide polymorphism is associated with non-contact musculoskeletal soft-tissue injury incidence in elite professional football players. Knee Surg Sports Traumatol Arthrosc 2019; 27: 4055-4061 DOI: 10.1007/s00167-019-05381-x.
• 44 Shang X, Huang C, Chang Q. et al. Association between the ACTN3 R577X polymorphism and female endurance athletes in China. Int J Sports Med 2010; 31: 913-916 DOI: 10.1055/s-0030-1265176.
• 45 Broos S, Malisoux L, Theisen D. et al. Role of alpha-actinin-3 in contractile properties of human single muscle fibers: a case series study in paraplegics. PLoS One 2012; 7: e49281 DOI: 10.1371/journal.pone.0049281.
• 46 Lucia A, Gómez-Gallego F, Santiago C. et al. ACTN3 genotype in professional endurance cyclists. Int J Sports Med 2006; 27: 880-884 DOI: 10.1055/s-2006-923862.
• 47 Houweling PJ, Papadimitriou ID, Seto JT. et al. Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and disease. Hum Mutat 2018; 39: 1774-1787 DOI: 10.1002/humu.23663.
• 48 Baltazar-Martins G, Gutiérrez-Hellín J, Aguilar-Navarro M. et al. Effect of ACTN3 genotype on sports performance, exercise-induced muscle damage, and injury epidemiology. Sports (Basel) 2020; 8: 99 DOI: 10.3390/sports8070099.
• 49 Echegaray M, Rivera MA. Role of creatine kinase isoenzymes on muscular and cardiorespiratory endurance: genetic and molecular evidence. Sports Med 2001; 31: 919-934 DOI: 10.2165/00007256-200131130-00003.
• 50 Bouchard C, Chagnon M, Thibault MC. et al. Muscle genetic variants and relationship with performance and trainability. Med Sci Sports Exerc 1989; 21: 71-77 DOI: 10.1249/00005768-198902000-00013.
• 51 Huang J, Gao N, Wang S. et al. Genetic approaches to identify pathological limitations in aortic smooth muscle contraction. PLoS One 2018; 13: e0193769 DOI: 10.1371/journal.pone.0193769.
• 52 Shen K, Ramirez B, Mapes B. et al. Structure-function analysis of the non-muscle myosin light chain kinase (nmMLCK) isoform by NMR spectroscopy and molecular modeling: influence of MYLK variants. PLoS One 2015; 10: e0130515 DOI: 10.1371/journal.pone.0130515.
• 53 Moreno V, Areces F, Ruiz-Vicente D. et al. Influence of the ACTN3 R577X genotype on the injury epidemiology of marathon runners. PLoS One 2020; 15: e0227548 DOI: 10.1371/journal.pone.0227548.
• 54 Gutiérrez-Hellín J, Baltazar-Martins G, Aguilar-Navarro M. et al. Effect of ACTN3 R577X genotype on injury epidemiology in elite endurance runners. Genes (Basel) 2021; 12: 76 DOI: 10.3390/genes12010076.
• 55 Joyner MJ. Genetic approaches for sports performance: how far away are we?. Sports Med 2019; 49: 199-204 DOI: 10.1007/s40279-019-01164-z.